- This event has passed.
Webinar | In China for China Strategy: The Roadmap to Localisation
November 3, 2022 | 5:00 pm - 6:30 pm
As part of its plans to achieve economic independence in more strategic sectors, China just released a series of measures prohibiting the import of foreign medical goods without prior government approval. While such decision will encourage medical institutions to source more domestic products, foreign manufacturers may have no choice but to localise production to remain competitive.
Why should you consider localising production?
Are there still sustainable alternatives to localisation?
How can you find the right talent to stay ahead of your competitors?
In this webinar titled “In China for China Strategy: The Roadmap to Localisation”, medical devices consulting firm Fiducia Management Consultants and regulatory affairs specialists Cisema jointly analysed the most recent regulatory updates for MedTech in China.
- Medtech in China in a post-pandemic world
- Latest regulatory updates & trends
- Greater Bay Area accessibility updates
- Analysis of market entry strategy options
- Localisation of production vs. selling without an entity
- Status quo of current talent hiring market
Pierre Gargatte, Senior Engagement Manager, Fiducia Management Consultants, Hong Kong
LIVE FROM BEIJING, HONG KONG, SHANGHAI:
Adrien Courson, Project Manager, Fiducia Executive Search, Shanghai
Hamish King, Chief Executive Officer, Cisema, Hong Kong
Marshall Chen, Partner, Fiducia Strategy Advisory, Shanghai
Ning Guo, General Manager, Cisema, Beijing
On 15 November 2022, we also held on site visits at the MEDICA 2022 in Dusseldorf.
Founded in 2002 in Munich, Germany and Beijing, China, Cisema has 12 offices globally and nearly 100 full-time employees. We’re a one-stop service provider for product certification, post market surveillance, clinical study, quality assurance and sourcing in China. We also act as local agent so international companies don’t have to set up an office in China.
Our solutions cover primarily Medical Device, IVD and Cosmetic registration as well as Drug Master Filing (DMF) with China’s NMPA (National Medical Product Administration). We also support companies with China Compulsory Certification (CCC), Manufacturing License (SELO) for pressure bearing parts, Energy Efficiency Labelling (CEL) etc. If you would like to learn more, feel free to subscribe to our monthly China certification newsletter.
Fiducia Management Consultants supports international companies in Greater China and APAC with a range of advisory and outsourced services. . For 40 years, Fiducia has helped clients navigate China’s complex but promising business landscape by delivering integrated solutions in corporate set-up, market advisory, tax and accounting, trade, and executive search.
Fiducia is a team of 130 experts in Beijing, Hong Kong, Shanghai, Shenzhen, and Singapore, which combines local know-how, global understanding, and industry-specific expertise.
- November 3, 2022
- 5:00 pm - 6:30 pm
- Event Category:
- Past Events
- Event Tags:
- Compliance, China
- Fiducia Management Consultants
- +852 2523 2171